Literature DB >> 3113952

Comparison of the sex and subcellular distributions, catalytic and immunochemical reactivities of hepatic epoxide hydrolases in seven mammalian species.

J Meijer, G Lundqvist, J W DePierre.   

Abstract

Sex and species differences in hepatic epoxide hydrolase activities towards cis- and trans-stilbene oxide were examined in common laboratory animals, as well as in monkey and man. In general trans-stilbene oxide was found to be a good substrate for epoxide hydrolase activity in cytosolic fractions, whereas the cis isomer was selectively hydrated by the microsomal fraction (with the exception of man, where the cytosol also hydrated this isomer efficiently). The specific cytosolic epoxide hydrolase activity was highest in mouse, followed by hamster and rabbit. Epoxide hydrolase activity in the crude 'mitochondrial' fraction towards trans-stilbene oxide was also highest in mouse and low in all other species examined. Microsomal epoxide hydrolase activity was highest in monkey, followed by guinea pig, human and rabbit, which all had similar activities. Sex differences were generally small, but where significant, male animals had higher catalytic activities than females of the same species in most cases. Antibodies raised against microsomal epoxide hydrolase purified from rat liver reacted with microsomes from all species investigated, indicating structural conservation of this protein. Antibodies directed towards cytosolic epoxide hydrolase purified from mouse liver reacted only with liver cytosol from mouse and hamster and with the 'mitochondrial' fraction from mouse in immunodiffusion experiments. Immunoblotting also revealed reaction with rat liver cytosol. The cytosolic and 'mitochondrial' epoxide hydrolases in all three mouse strains and in both sexes for each strain were immunochemically identical. The anomalies in human liver epoxide hydrolase activities observed here indicate that no single common laboratory animal is a good model for man with regard to these activities.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3113952     DOI: 10.1111/j.1432-1033.1987.tb13333.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Estrogen-dependent epigenetic regulation of soluble epoxide hydrolase via DNA methylation.

Authors:  Yang-Ming Yang; Dong Sun; Sharath Kandhi; Ghezal Froogh; Jian Zhuge; Weihua Huang; Bruce D Hammock; An Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-02       Impact factor: 11.205

2.  Soluble epoxide hydrolase inhibition alleviates neuropathy in Akita (Ins2 Akita) mice.

Authors:  Karen Wagner; Jennifer Gilda; Jun Yang; Debin Wan; Christophe Morisseau; Aldrin V Gomes; Bruce D Hammock
Journal:  Behav Brain Res       Date:  2017-03-01       Impact factor: 3.332

3.  Mitochondrial P450-dependent arachidonic acid metabolism by TCDD-induced hepatic CYP1A5; conversion of EETs to DHETs by mitochondrial soluble epoxide hydrolase.

Authors:  Erin M Labitzke; Silvia Diani-Moore; Arleen B Rifkind
Journal:  Arch Biochem Biophys       Date:  2007-08-25       Impact factor: 4.013

4.  Rat and human liver cytosolic epoxide hydrolases: evidence for multiple forms at level of protein and mRNA.

Authors:  H Thomas; L Schladt; J Doehmer; M Knehr; F Oesch
Journal:  Environ Health Perspect       Date:  1990-08       Impact factor: 9.031

5.  Sexually dimorphic adaptation of cardiac function: roles of epoxyeicosatrienoic acid and peroxisome proliferator-activated receptors.

Authors:  Jun Qin; Yicong Le; Ghezal Froogh; Sharath Kandhi; Houli Jiang; Meng Luo; Dong Sun; An Huang
Journal:  Physiol Rep       Date:  2016-06

6.  Soluble Epoxide Hydrolase Deletion Limits High-Fat Diet-Induced Inflammation.

Authors:  Karen M Wagner; Jun Yang; Christophe Morisseau; Bruce D Hammock
Journal:  Front Pharmacol       Date:  2021-12-17       Impact factor: 5.810

Review 7.  Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products.

Authors:  Cheng-Peng Sun; Xin-Yue Zhang; Christophe Morisseau; Sung Hee Hwang; Zhan-Jun Zhang; Bruce D Hammock; Xiao-Chi Ma
Journal:  J Med Chem       Date:  2020-12-28       Impact factor: 7.446

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.